Baxter International Quarterly Cash Flow Statement
NYSE: BAXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Baxter International free cash flow
In the quarter ended Jun 30, 2026, Baxter International generated $285.0 million of operating cash flow. That left free cash flow of $285.0 million, a free-cash-flow margin of 9.6% of revenue. Free cash flow was up 31.3% from the prior year's $217.0 million.
Baxter International returned $5.0 million to shareholders through dividends, equal to 2% of free cash flow. Free cash flow covered dividend payments 57.0 times.
Summary generated from market data by MetaCap's automated system. Methodology
Baxter International cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 126.00M | -15.00M | -1.13B | -46.00M | 91.00M | 126.00M | -510.00M | 144.00M | -311.00M | 39.00M | 246.00M | 2.51B |
| Net Income growth (YoY) | +38.46% | -111.90% | — | -131.94% | — | +223.08% | -307.32% | -94.27% | — | -13.33% | +32.97% | — |
| Depreciation & Amortization | 239.00M | 237.00M | 240.00M | 237.00M | 257.00M | 247.00M | 245.00M | 254.00M | 227.00M | 271.00M | 264.00M | 92.00M |
| Stock-Based Compensation | 33.00M | 10.00M | 37.00M | 35.00M | 35.00M | 10.00M | 39.00M | 38.00M | 20.00M | 17.00M | 25.00M | 28.00M |
| Change in Working Capital | -70.00M | 161.00M | 296.00M | -184.00M | -184.00M | -104.00M | 6.00M | -58.00M | -292.00M | 95.00M | -171.00M | 41.00M |
| Operating Cash Flow | 285.00M | 213.00M | 584.00M | 237.00M | 217.00M | -193.00M | 488.00M | 253.00M | 115.00M | 163.00M | 531.00M | 365.00M |
| Capital Expenditures | — | — | — | — | — | — | — | — | — | — | 70.00M | -174.00M |
| Investing Cash Flow | -117.00M | -133.00M | -198.00M | -111.00M | -115.00M | 3.27B | -205.00M | -164.00M | -91.00M | -166.00M | -230.00M | 3.79B |
| Dividends Paid | -5.00M | -5.00M | -87.00M | -87.00M | -87.00M | -87.00M | -147.00M | -148.00M | -148.00M | -147.00M | -147.00M | -147.00M |
| Share Repurchases | — | — | — | — | — | — | — | — | — | — | 0 | — |
| Debt Repaid | 0 | 0 | -1.98B | 0 | -680.00M | -2.83B | -1.83B | -3.00M | -809.00M | -15.00M | -2.28B | -211.00M |
| Financing Cash Flow | -31.00M | -11.00M | -147.00M | -81.00M | -762.00M | -3.23B | 141.00M | -146.00M | -936.00M | -140.00M | -2.94B | -62.00M |
| Net Change in Cash | 137.00M | 51.00M | 240.00M | 40.00M | -608.00M | -118.00M | 334.00M | -16.00M | -934.00M | -168.00M | -2.59B | 4.07B |
| Free Cash Flow | 285.00M | 213.00M | 584.00M | 237.00M | 217.00M | -193.00M | 488.00M | 253.00M | 115.00M | 163.00M | 601.00M | 191.00M |
This table shows 12 quarterly periods of Baxter International's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BAX's reporting calendar. What is a cash flow statement?